Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 30 studies | 28% ± 9% | |
natural killer cell | 24 studies | 27% ± 8% | |
conventional dendritic cell | 17 studies | 30% ± 11% | |
CD16-positive, CD56-dim natural killer cell, human | 14 studies | 27% ± 8% | |
myeloid cell | 13 studies | 29% ± 12% | |
microglial cell | 12 studies | 37% ± 15% | |
dendritic cell | 11 studies | 31% ± 13% | |
CD16-negative, CD56-bright natural killer cell, human | 10 studies | 23% ± 8% | |
monocyte | 7 studies | 25% ± 8% | |
classical monocyte | 7 studies | 22% ± 4% | |
non-classical monocyte | 6 studies | 23% ± 3% | |
mononuclear phagocyte | 5 studies | 25% ± 8% | |
alveolar macrophage | 4 studies | 30% ± 10% | |
exhausted T cell | 4 studies | 34% ± 11% | |
mature NK T cell | 4 studies | 24% ± 9% | |
mast cell | 3 studies | 19% ± 1% | |
CD8-positive, alpha-beta T cell | 3 studies | 27% ± 12% | |
oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 96% | 553.40 | 441 / 459 | 97% | 21.89 | 1081 / 1118 |
kidney | 98% | 1917.82 | 87 / 89 | 92% | 72.83 | 833 / 901 |
lung | 100% | 1969.98 | 578 / 578 | 90% | 21.82 | 1034 / 1155 |
brain | 91% | 494.68 | 2400 / 2642 | 95% | 38.65 | 668 / 705 |
bladder | 95% | 334.95 | 20 / 21 | 62% | 11.25 | 314 / 504 |
intestine | 91% | 342.44 | 876 / 966 | 61% | 9.30 | 324 / 527 |
adrenal gland | 99% | 685.22 | 255 / 258 | 37% | 4.08 | 86 / 230 |
uterus | 55% | 137.78 | 94 / 170 | 75% | 12.71 | 345 / 459 |
thymus | 62% | 193.67 | 403 / 653 | 69% | 9.23 | 415 / 605 |
stomach | 56% | 157.86 | 202 / 359 | 72% | 11.03 | 207 / 286 |
skin | 49% | 112.15 | 886 / 1809 | 78% | 19.42 | 368 / 472 |
esophagus | 64% | 191.71 | 924 / 1445 | 62% | 8.25 | 114 / 183 |
prostate | 84% | 293.29 | 207 / 245 | 40% | 3.43 | 201 / 502 |
pancreas | 36% | 105.47 | 117 / 328 | 88% | 18.92 | 157 / 178 |
ovary | 41% | 102.15 | 73 / 180 | 80% | 12.89 | 343 / 430 |
liver | 61% | 200.95 | 138 / 226 | 41% | 6.11 | 167 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 66.96 | 29 / 29 |
spleen | 100% | 2027.01 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2004.27 | 924 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 975.36 | 1197 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 18.63 | 41 / 45 |
blood vessel | 83% | 463.57 | 1114 / 1335 | 0% | 0 | 0 / 0 |
heart | 60% | 170.49 | 517 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 2.44 | 16 / 80 |
muscle | 9% | 19.24 | 73 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002826 | Biological process | negative regulation of T-helper 1 type immune response |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0006954 | Biological process | inflammatory response |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0034154 | Biological process | toll-like receptor 7 signaling pathway |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0030886 | Biological process | negative regulation of myeloid dendritic cell activation |
GO_0032687 | Biological process | negative regulation of interferon-alpha production |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0032712 | Biological process | negative regulation of interleukin-3 production |
GO_0045087 | Biological process | innate immune response |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0034138 | Biological process | toll-like receptor 3 signaling pathway |
GO_2000521 | Biological process | negative regulation of immunological synapse formation |
GO_0002519 | Biological process | natural killer cell tolerance induction |
GO_0032732 | Biological process | positive regulation of interleukin-1 production |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0043032 | Biological process | positive regulation of macrophage activation |
GO_0071656 | Biological process | negative regulation of granulocyte colony-stimulating factor production |
GO_0002250 | Biological process | adaptive immune response |
GO_0002859 | Biological process | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
GO_0002652 | Biological process | regulation of tolerance induction dependent upon immune response |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0032815 | Biological process | negative regulation of natural killer cell activation |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_2001189 | Biological process | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0002281 | Biological process | macrophage activation involved in immune response |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_1900425 | Biological process | negative regulation of defense response to bacterium |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_1900426 | Biological process | positive regulation of defense response to bacterium |
GO_0034162 | Biological process | toll-like receptor 9 signaling pathway |
GO_0060135 | Biological process | maternal process involved in female pregnancy |
GO_0001772 | Cellular component | immunological synapse |
GO_0016592 | Cellular component | mediator complex |
GO_0005769 | Cellular component | early endosome |
GO_0009986 | Cellular component | cell surface |
GO_0070161 | Cellular component | anchoring junction |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HAVCR2 |
Protein name | Hepatitis A virus cellular receptor 2 (HAVcr-2) (T-cell immunoglobulin and mucin domain-containing protein 3) (TIMD-3) (T-cell immunoglobulin mucin receptor 3) (TIM-3) (T-cell membrane protein 3) (CD antigen CD366) Hepatitis A virus cellular receptor 2 |
Synonyms | TIM3 TIMD3 |
Description | FUNCTION: Cell surface receptor implicated in modulating innate and adaptive immune responses. Generally accepted to have an inhibiting function. Reports on stimulating functions suggest that the activity may be influenced by the cellular context and/or the respective ligand . Regulates macrophage activation . Inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance . In CD8+ cells attenuates TCR-induced signaling, specifically by blocking NF-kappaB and NFAT promoter activities resulting in the loss of IL-2 secretion. The function may implicate its association with LCK proposed to impair phosphorylation of TCR subunits, and/or LGALS9-dependent recruitment of PTPRC to the immunological synapse . In contrast, shown to activate TCR-induced signaling in T-cells probably implicating ZAP70, LCP2, LCK and FYN (By similarity). Expressed on Treg cells can inhibit Th17 cell responses . Receptor for LGALS9 . Binding to LGALS9 is believed to result in suppression of T-cell responses; the resulting apoptosis of antigen-specific cells may implicate HAVCR2 phosphorylation and disruption of its association with BAG6. Binding to LGALS9 is proposed to be involved in innate immune response to intracellular pathogens. Expressed on Th1 cells interacts with LGALS9 expressed on Mycobacterium tuberculosis-infected macrophages to stimulate antibactericidal activity including IL-1 beta secretion and to restrict intracellular bacterial growth (By similarity). However, the function as receptor for LGALS9 has been challenged . Also reported to enhance CD8+ T-cell responses to an acute infection such as by Listeria monocytogenes (By similarity). Receptor for phosphatidylserine (PtSer); PtSer-binding is calcium-dependent. May recognize PtSer on apoptotic cells leading to their phagocytosis. Mediates the engulfment of apoptotic cells by dendritic cells. Expressed on T-cells, promotes conjugation but not engulfment of apoptotic cells. Expressed on dendritic cells (DCs) positively regulates innate immune response and in synergy with Toll-like receptors promotes secretion of TNF-alpha. In tumor-imfiltrating DCs suppresses nucleic acid-mediated innate immune repsonse by interaction with HMGB1 and interfering with nucleic acid-sensing and trafficking of nucleid acids to endosomes (By similarity). Expressed on natural killer (NK) cells acts as a coreceptor to enhance IFN-gamma production in response to LGALS9 . In contrast, shown to suppress NK cell-mediated cytotoxicity . Negatively regulates NK cell function in LPS-induced endotoxic shock (By similarity). . |
Accessions | E5RHN3 E5RFR4 ENST00000524219.2 A0A8Q3SJ15 ENST00000522593.6 ENST00000696901.1 ENST00000696902.1 A0A8V8TMM7 Q8TDQ0 ENST00000521665.2 ENST00000696900.1 ENST00000517358.3 ENST00000696897.1 ENST00000307851.9 [Q8TDQ0-1] A0A8Q3SJ74 A0A8Q3SIX1 ENST00000696899.1 [Q8TDQ0-1] |